STRATA Skin Sciences Announces CFO Transition
Retrieved on:
Monday, October 4, 2021
Bachelor of Science, Midcap, Vitiligo, Social media, Â, Insurance, IDBNY, Form 10-Q, Certified Public Accountant, Laser, Time deposit, Pain management, Private Securities Litigation Reform Act, NASDAQ, LIBOR, Patient, CPA, Dermatitis, Strata Skin Sciences, Assignment, Controller, Dermatology, Villanova University, Marketing, COVID-19 vaccine, Acquisition, Lighthouse of Alexandria, Company, Coronavirus, LLC, Psoriasis, Growth, Israel, Awareness, Atopic dermatitis, COVID-19, Commonwealth, CFO, DTC, Israel Discount Bank, UVB, SEC, STRATA, GLOBE, Security (finance), Medical imaging
Having previously worked with Chris at Encore Dermatology, where he successfully led the financial organization, we were delighted to add him to the STRATA team.
Key Points:
- Having previously worked with Chris at Encore Dermatology, where he successfully led the financial organization, we were delighted to add him to the STRATA team.
- In an 8-K filed today, STRATA announced that it has completed an $8 million financing with MidCap Financial Trust (MidCap).
- STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions.
- Its products include the XTRAC and now Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.